Aisthesis Medical specializes in providing AI-driven decision support for acute care to prevent complications and enhance patient outcomes.
Aisthesis Medical has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2025.
Aisthesis Medical's investors include Twin Path Ventures, Centre for Process Innovation, Eureka Network, Ready2Scale, TECS Capital.
Aisthesis Medical is headquartered in London, United Kingdom.
Aisthesis Medical specializes in providing AI-driven decision support for acute care to prevent complications and enhance patient outcomes.
Aisthesis Medical is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aisthesis Medical — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/aisthesis-medical. Accessed August 1, 2026.
VCBacked. (2025). Aisthesis Medical — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/aisthesis-medical
{{cite web |title=Aisthesis Medical — Funding & Investors |url=https://www.vcbacked.co/company/aisthesis-medical |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated